España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Editas Medicine
EDIT
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$5.58
-0.03
-0.53%
Pre-Market: 7:58 PM EDT
15 minutes delayed
Get Report
Comment
Editas Medicine (EDIT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Editas Medicine (NASDAQ:EDIT) Stock
Editas Medicine Stock (NASDAQ: EDIT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, June 18, 2024
Unveiling 5 Analyst Insights On Editas Medicine
Benzinga Insights
Oppenheimer Maintains Perform on Editas Medic...
Benzinga Newsdesk
Friday, June 14, 2024
Editas Medicine Unveils Updated Safety And Ef...
Benzinga Newsdesk
Editas Medicine Reveals Updated Safety And Ef...
Benzinga Newsdesk
Thursday, May 30, 2024
The Analyst Verdict: Editas Medicine In The Eyes Of 4 Experts
Benzinga Insights
Evercore ISI Group Maintains In-Line on Edita...
Benzinga Newsdesk
Tuesday, May 14, 2024
Editas Medicine To Present Clinical Data From...
Benzinga Newsdesk
Friday, May 10, 2024
Editas Medicine Reports Presentation Of Precl...
Benzinga Newsdesk
Thursday, May 09, 2024
Citigroup Maintains Buy on Editas Medicine, L...
Benzinga Newsdesk
Morgan Stanley Upgrades Editas Medicine to Eq...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Editas Med...
Benzinga Newsdesk
Wednesday, May 08, 2024
Editas Medicine Q1 2024 Adj EPS $(0.76) Misse...
Benzinga Newsdesk
Wednesday, May 01, 2024
Editas Medicine Announced A Two-year Extensio...
Benzinga Newsdesk
Monday, April 22, 2024
Editas Medicine To Present Pre-Clinical Data ...
Benzinga Newsdesk
Thursday, February 29, 2024
The Latest Analyst Ratings For Editas Medicine
Benzinga Insights
Citigroup Maintains Buy on Editas Medicine, R...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Editas Med...
Benzinga Newsdesk
Wednesday, February 28, 2024
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Editas Medicine shares ar trading higher afte...
Benzinga Newsdesk
Editas Medicine Q4 EPS $(0.23) Beats $(0.54) ...
Benzinga Newsdesk
Earnings Scheduled For February 28, 2024
Benzinga Insights
Tuesday, February 27, 2024
JP Morgan Maintains Neutral on Editas Medicin...
Benzinga Newsdesk
Earnings Outlook For Editas Medicine
Benzinga Insights
Monday, January 08, 2024
Editas Medicine Highlights 2024 Anticipated M...
Benzinga Newsdesk
Wednesday, December 13, 2023
Editas Medicine Announced It Entered Into A L...
Benzinga Newsdesk
Tuesday, December 12, 2023
The Latest Analyst Ratings for Editas Medicine
Benzinga Insights
Truist Securities Maintains Buy on Editas Med...
Benzinga Newsdesk
Monday, December 11, 2023
Editas Medicine Announces New EDIT-301 Safety...
Benzinga Newsdesk
Friday, November 03, 2023
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Editas Medicine shares are trading higher aft...
Benzinga Newsdesk
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
Lisa Levin
Earnings Scheduled For November 3, 2023
Benzinga Insights
Editas Medicine's Cash, Cash Equivalents, And...
Benzinga Newsdesk
Editas Medicine Q3 EPS $(0.55) Beats $(0.57) ...
Benzinga Newsdesk
Thursday, November 02, 2023
A Preview Of Editas Medicine's Earnings
Benzinga Insights
Editas Medicine To Present Clinical Data From...
Benzinga Newsdesk
Tuesday, October 24, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
Benzinga Insights
Citigroup Upgrades Editas Medicine to Buy, An...
Benzinga Newsdesk
Wednesday, October 18, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
Benzinga Insights
Analyst Ratings for Editas Medicine
Benzinga Insights
JP Morgan Upgrades Editas Medicine to Neutral...
Benzinga Newsdesk
Tuesday, October 17, 2023
Editas Medicine Has To Navigate Sickle Cell Therapy Competition: Analyst
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
Benzinga Insights
Cantor Fitzgerald Downgrades Editas Medicine ...
Benzinga Newsdesk
NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
Monday, October 16, 2023
The FDA Has Granted Regenerative Medicine Adv...
Benzinga Newsdesk
Friday, September 29, 2023
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock
Vandana Singh
Expert Ratings for Editas Medicine
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch